Skip to main content

Animations

MJFF Publications

4901 - 4910 of 6547 Results
Title
Year
  • Year
  • 2023
  • 2024
  • 2016
  • 2025
  • 2020
  • 2017
  • 2016
  • 2016
  • 2017
  • 2014
  • Summary Details
    OPEN
    Title: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Genetic and clinical study of PARK7 in Japanese Parkinson's disease
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2024.e35271
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cortex.2016.07.004
    Citation Count: 23
  • Summary Details
    OPEN
    Title: The role of autophagy in synucleinopathy: clearance versus spread of α-synuclein
    Journal Name: Autophagy Reports
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/27694127.2025.2577406
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Prevalence of GBA p.K198E mutation in Colombian and Hispanic populations
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.03.008
    Citation Count: 7
  • Summary Details
    OPEN
    Title: The LRR-Roc-COR module of theChlorobium tepidumRoco protein: crystallization and X-ray crystallographic analysis
    Journal Name: Acta Crystallographica Section F Structural Biology Communications
    Publisher: International Union of Crystallography (IUCr)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1107/s2053230x17011955
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Novel method to ascertain chromatin accessibility at specific genomic loci from frozen brain homogenates and laser capture microdissected defined cells
    Journal Name: Neuroepigenetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nepig.2016.03.001
    Citation Count: 0
  • LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies
    2016
    Summary Details
    OPEN
    Title: LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26892
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Distinct alterations in Parkinson's medication-state and disease-state connectivity
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.09.004
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011
    Citation Count: 70
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.